Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gadolinium-enhanced brain lesions in multiple sclerosis relapse.
Martín-Aguilar L, Presas-Rodriguez S, Rovira À, Capellades J, Massuet-Vilamajó A, Ramió-Torrentà L, Tintoré M, Brieva-Ruiz L, Moral E, Cano-Orgaz A, Blanco Y, Batlle-Nadal J, Carmona O, Gea M, Hervás-García JV, Ramo-Tello C. Martín-Aguilar L, et al. Among authors: presas rodriguez s. Neurologia (Engl Ed). 2022 Sep;37(7):557-563. doi: 10.1016/j.nrleng.2021.10.005. Neurologia (Engl Ed). 2022. PMID: 36064284 Free article. Clinical Trial.
[Lesion of the trigeminal nucleus caused by herpes simplex virus].
Presas-Rodríguez S, Hernández-Pérez M, Grau-López L, Massuet-Vilamajó A, Ramo-Tello C. Presas-Rodríguez S, et al. Rev Neurol. 2013 Dec 1;57(11):526-7. Rev Neurol. 2013. PMID: 24265148 Free article. Spanish. No abstract available.
Myelitis: Differences between multiple sclerosis and other aetiologies.
Presas-Rodríguez S, Grau-López L, Hervás-García JV, Massuet-Vilamajó A, Ramo-Tello C. Presas-Rodríguez S, et al. Neurologia. 2016 Mar;31(2):71-5. doi: 10.1016/j.nrl.2015.07.006. Epub 2015 Sep 14. Neurologia. 2016. PMID: 26383061 Free article. English, Spanish.
Monitoring CD49d Receptor Occupancy: A Method to Optimize and Personalize Natalizumab Therapy in Multiple Sclerosis Patients.
Puñet-Ortiz J, Hervás-García JV, Teniente-Serra A, Cano-Orgaz A, Mansilla MJ, Quirant-Sánchez B, Navarro-Barriuso J, Fernández-Sanmartín MA, Presas-Rodríguez S, Ramo-Tello C, Martínez-Cáceres EM. Puñet-Ortiz J, et al. Cytometry B Clin Cytom. 2018 Mar;94(2):327-333. doi: 10.1002/cyto.b.21527. Epub 2017 Apr 17. Cytometry B Clin Cytom. 2018. PMID: 28378895 Free article.
Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates.
Sepúlveda M, Aldea M, Escudero D, Llufriu S, Arrambide G, Otero-Romero S, Sastre-Garriga J, Romero-Pinel L, Martínez-Yélamos S, Sola-Valls N, Armangué T, Sotoca J, Escartín A, Robles-Cedeño R, Ramió-Torrentà L, Presas-Rodríguez S, Ramo-Tello C, Munteis E, Pelayo R, Gubieras L, Brieva L, Ortiz N, Hervás M, Mañé-Martínez MA, Cano A, Vela E, Tintoré M, Blanco Y, Montalban X, Graus F, Saiz A. Sepúlveda M, et al. Mult Scler. 2018 Dec;24(14):1843-1851. doi: 10.1177/1352458517735191. Epub 2017 Oct 6. Mult Scler. 2018. PMID: 28984163
Predicting therapeutic response to fingolimod treatment in multiple sclerosis patients.
Quirant-Sánchez B, Hervás-García JV, Teniente-Serra A, Brieva L, Moral-Torres E, Cano A, Munteis E, Mansilla MJ, Presas-Rodriguez S, Navarro-Barriuso J, Ramo-Tello C, Martínez-Cáceres EM. Quirant-Sánchez B, et al. CNS Neurosci Ther. 2018 Dec;24(12):1175-1184. doi: 10.1111/cns.12851. Epub 2018 Apr 15. CNS Neurosci Ther. 2018. PMID: 29656444 Free PMC article.
Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double-blind, non-inferiority trial.
Hervás-García JV, Ramió-Torrentà L, Brieva-Ruiz L, Batllé-Nadal J, Moral E, Blanco Y, Cano-Orgaz A, Presas-Rodríguez S, Torres F, Capellades J, Ramo-Tello C. Hervás-García JV, et al. Eur J Neurol. 2019 Mar;26(3):525-532. doi: 10.1111/ene.13851. Epub 2018 Nov 16. Eur J Neurol. 2019. PMID: 30351511 Clinical Trial.
30 results